Market Research Logo

Human Insulin Market - Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications (Type 1 Diabetes, Type 2 Diabetes) - Forecasts to 2020

Human Insulin Market - Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications (Type 1 Diabetes, Type 2 Diabetes) - Forecasts to 2020

The global human insulin market is poised to reach ~USD 39.13 billion by 2020 growing at a CAGR of 8.1% from 2015 to 2020. North America is expected to hold the largest share of the global human insulin market in 2015. Market growth of human insulin products is being propelled by growing diabetes patient population, increasing population exposure to key risk factors leading to diabetes, rising market demand for human insulin analogs, technological advancements in the field of human insulin delivery devices, and favorable medical reimbursements. However, stringent regulatory requirements for product approval are restraining the growth of human insulin market. In addition, high product manufacturing costs is posing significant challenges for market growth during the forecast period.

In this report, the global human insulin market is segmented on the basis of basis of products (human insulin biologics, insulin analogs & biosimilars, and delivery devices), drug type (rapid-acting, intermediate-acting, long-acting, short-acting, and premixed), drug brand (Lantus, NovoRapid/Novolog, Humalog, Humulin, Insuman, Actrapid, Insulatard, Mixtard, and Other Biosimilar Brands), delivery devices [insulin pens (reusable & disposable), pen needles (standard & safety), and conventional syringes], and applications (type I diabetes & type II diabetes).

Human insulin drugs segment is expected to account for the larger share of the global human insulin market in 2015, followed by insulin delivery devices. Significant demand growth for human insulin drugs during the next five years is owing to factors such as increasing market accessibility of generic human insulin products worldwide, rising government initiatives to support the development and commercialization of effective biosimilars, growing R&D for drug discovery & development, and rising proportion of aging population in developed countries.

Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the global human insulin market in 2015, followed by Europe. Asia-Pacific is also poised to grow at the highest CAGR during the forecast period, owing to factors such as growing diabetes prevalence in APAC (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, evolving regulatory framework for marketing approvals & medical reimbursements, and rising public awareness related to benefits offered by human insulin in diabetes treatment (as compared to anti-diabetic drugs & animal derived insulin).

The global human insulin market is highly competitive, with various global as well as local players. In 2014, the global human insulin devices market was dominated by Sanofi (France), Novo Nordisk A/S (Denmark), and Eli Lilly and Company (U.S.), which together accounted for ~89.0% of the human insulin market. Geographic expansion, new product launches, agreements, collaborations, partnerships, awareness campaigns, and offering research fund & grants are the major strategies adopted by most market players to achieve growth in the global human insulin market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis such as market share analysis of the top ten players and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the human insulin market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms to garner higher market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the human insulin products offered by the top 10 players in the global market. The report analyzes the human insulin market by product, drug type, drug brand, delivery devices, and applications across key geographic regions

Product Development/Innovation: Detailed insights on upcoming human insulin products, product pipeline, research and development activities, and new product launches in the market

Market Development: Comprehensive information on lucrative emerging markets. The report analyzes the markets for various human insulin products across key geographic regions

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global human insulin market

Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the global human insulin market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • RESEARCH ASSUMPTIONS
      • ASSUMPTIONS
  • EXECUTIVE SUMMARY
    • INTRODUCTION
    • CURRENT MARKET SCENARIO
    • FUTURE OUTLOOK
    • CONCLUSION
  • PREMIUM INSIGHTS
    • GLOBAL HUMAN INSULIN MARKET (2015-2020)
    • GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY TYPE (2015)
    • GLOBAL HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE (2015-2020)
    • GLOBAL HUMAN INSULIN DRUGS MARKET, BY BRAND (2015 VS. 2020)
    • GLOBAL HUMAN INSULIN PRODUCTS MARKET SIZE, BY COUNTRY (2015-2020)
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET SEGMENTATION
    • MARKET EVOLUTION
      • Table KEY HUMAN INSULIN DRUGS: YEAR OF PATENT EXPIRY
    • MARKET DYNAMICS
      • KEY MARKET DRIVERS
      • KEY MARKET RESTRAINTS
      • KEY MARKET OPPORTUNITIES
      • KEY MARKET CHALLENGE
  • INDUSTRY INSIGHTS
    • INTRODUCTION
    • INDUSTRY TRENDS
      • GROWING MARKET DEMAND FOR HUMAN INSULIN PENS
      • INCREASING MARKET FOCUS ON THE PIPELINE DEVELOPMENT OF NOVEL HUMAN INSULIN THERAPIES
        • Table KEY HUMAN INSULIN THERAPIES UNDER PIPELINE DEVELOPMENT & COMMERCIALIZATION: 2005-2015
    • PIPELINE ANALYSIS
      • BY COMPANY
        • Table HUMAN INSULIN PIPELINE: MAJOR COMPANIES INVOLVED
      • BY CLINICAL TRIAL PHASE
        • Table HUMAN INSULIN PIPELINE: STAGES OF CLINICAL TRIAL
      • PORTER'S FIVE FORCE ANALYSIS
  • GLOBAL HUMAN INSULIN MARKET, BY PRODUCT TYPE
    • INTRODUCTION
      • Table GLOBAL HUMAN INSULIN MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
    • HUMAN INSULIN DRUGS
      • Table HUMAN INSULIN DRUGS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
    • HUMAN INSULIN DELIVERY DEVICES
      • Table HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • GLOBAL HUMAN INSULIN DRUGS MARKET, BY TYPE
    • INTRODUCTION
      • Table GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
    • INSULIN ANALOGS AND BIOSIMILARS
      • Table GLOBAL INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • LONG-ACTING
        • Table LONG-ACTING INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • RAPID-ACTING
        • Table RAPID-ACTING INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • PREMIXED
        • Table PREMIXED INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
    • HUMAN INSULIN BIOLOGICS
      • Table GLOBAL HUMAN INSULIN BIOLOGICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table HUMAN INSULIN BIOLOGICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • SHORT-ACTING
        • Table SHORT-ACTING HUMAN INSULIN BIOLOGICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • INTERMEDIATE-ACTING
        • Table INTERMEDIATE-ACTING HUMAN INSULIN BIOLOGICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • PREMIXED
        • Table PREMIXED HUMAN INSULIN BIOLOGICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • GLOBAL HUMAN INSULIN DRUGS MARKET, BY BRAND
    • INTRODUCTION
      • Table GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
    • INSULIN ANALOGS AND BIOSIMILARS
      • Table GLOBAL INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY BRAND, 2013-2020 (USD MILLION)
      • Table INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • LANTUS
        • Table INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE FOR LANTUS, BY REGION, 2013-2020 (USD MILLION)
      • NOVORAPID AND NOVOLOG
        • Table INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE FOR NOVORAPID AND NOVOLOG, BY REGION, 2013-2020 (USD MILLION)
      • HUMALOG
        • Table INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE FOR HUMALOG, BY REGION, 2013-2020 (USD MILLION)
      • OTHER BRANDS
        • Table INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE FOR OTHER BRANDS, BY REGION, 2013-2020 (USD MILLION)
    • HUMAN INSULIN BIOLOGICS
      • Table GLOBAL HUMAN INSULIN BIOLOGICS MARKET SIZE, BY BRAND, 2013-2020 (USD MILLION)
      • Table HUMAN INSULIN BIOLOGICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • ACTRAPID, MIXTARD, AND INSULATARD
        • Table HUMAN INSULIN BIOLOGICS MARKET SIZE FOR ACTRAPID, MIXTARD, AND INSULATARD, BY REGION, 2013-2020 (USD MILLION)
      • HUMULIN
        • Table HUMAN INSULIN BIOLOGICS MARKET SIZE FOR HUMULIN, BY REGION, 2013-2020 (USD MILLION)
      • INSUMAN
        • Table HUMAN INSULIN BIOLOGICS MARKET SIZE FOR INSUMAN, BY REGION, 2013-2020 (USD MILLION)
  • GLOBAL HUMAN INSULIN MARKET, BY DELIVERY DEVICE
    • INTRODUCTION
      • Table GLOBAL HUMAN INSULIN MARKET SIZE, BY DELIVERY DEVICE, 2013-2020 (USD MILLION)
    • HUMAN INSULIN PENS
      • Table GLOBAL HUMAN INSULIN PENS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
      • Table HUMAN INSULIN PENS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • REUSABLE PENS
        • Table REUSABLE HUMAN INSULIN PENS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • DISPOSABLE PENS
        • Table DISPOSABLE HUMAN INSULIN PENS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
    • HUMAN INSULIN PEN NEEDLES
      • Table GLOBAL HUMAN INSULIN PEN NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
      • Table HUMAN INSULIN PEN NEEDLES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • STANDARD PEN NEEDLES
        • Table HUMAN INSULIN STANDARD PEN NEEDLES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • SAFETY PEN NEEDLES
        • Table HUMAN INSULIN SAFETY PEN NEEDLES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
    • HUMAN INSULIN SYRINGES
      • Table HUMAN INSULIN SYRINGES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • GLOBAL HUMAN INSULIN MARKET, BY APPLICATION
    • INTRODUCTION
    • TYPE I DIABETES
    • TYPE II DIABETES
  • HUMAN INSULIN MARKET, BY REGION
    • INTRODUCTION
      • Table HUMAN INSULIN MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: HUMAN INSULIN MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: HUMAN INSULIN MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • U.S.
        • Table U.S.: HUMAN INSULIN MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table U.S.: HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table U.S.: HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • CANADA
        • Table CANADA: HUMAN INSULIN MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table CANADA: HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table CANADA: HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
    • EUROPE
      • Table EUROPE: HUMAN INSULIN MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
      • Table EUROPE: HUMAN INSULIN MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • Table EUROPE: HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • Table EUROPE: HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • GERMANY
        • Table GERMANY: HUMAN INSULIN MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table GERMANY: HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table GERMANY: HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • FRANCE
        • Table FRANCE: HUMAN INSULIN MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table FRANCE: HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table FRANCE: HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • U.K.
        • Table U.K.: HUMAN INSULIN MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table U.K.: HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table U.K.: HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • REST OF EUROPE (ROE)
        • Table ROE: HUMAN INSULIN MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table ROE: HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table ROE: HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
    • ASIA-PACIFIC (APAC)
      • Table APAC: HUMAN INSULIN MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
      • Table APAC: HUMAN INSULIN MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • Table APAC: HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • Table APAC: HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • JAPAN
        • Table JAPAN: HUMAN INSULIN MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table JAPAN: HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table JAPAN: HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • CHINA
        • Table CHINA: HUMAN INSULIN MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table CHINA: HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table CHINA: HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • INDIA
        • Table INDIA: HUMAN INSULIN MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table INDIA: HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table INDIA: HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • REST OF ASIA-PACIFIC (ROAPAC)
        • Table ROAPAC: HUMAN INSULIN MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table ROAPAC: HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
        • Table ROAPAC: HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
    • REST OF THE WORLD (RoW)
      • Table ROW: HUMAN INSULIN MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • Table ROW: HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • Table ROW: HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
      • HUMAN INSULIN DRUGS MARKET
      • HUMAN INSULIN DELIVERY DEVICES MARKET
    • COMPETITIVE SCENARIO
    • RECENT DEVELOPMENTS
      • GEOGRAPHICAL EXPANSIONS
        • Table GEOGRAPHICAL EXPANSIONS, 2012-2015
      • AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
        • Table AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2012-2015
      • NEW PRODUCT LAUNCHES
        • Table NEW PRODUCT LAUNCHES AND PRODUCT APPROVALS, 2012-2015
      • AWARENESS PROGRAMS
        • Table AWARENESS PROGRAMS, 2012-2015
      • FUNDING & SCHOLARSHIPS
        • Table FUNDING & SCHOLARSHIPS, 2012-2015
      • STRATEGIC ACQUISITIONS
        • Table STRATEGIC ACQUISITIONS, 2012-2015
  • COMPANY PROFILES
    • INTRODUCTION
      • GEOGRAPHIC BENCHMARKING
      • STRATEGIC BENCHMARKING
    • B. BRAUN MELSUNGEN AG
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS
    • BECTON, DICKINSON AND COMPANY
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS
    • BIOCON LIMITED
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIODEL INC.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS
    • ELI LILLY AND COMPANY
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • JULPHAR (ALSO KNOWN AS GULF PHARMACEUTICAL INDUSTRIES)
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • NOVO NORDISK A/S
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SANOFI
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • WOCKHARDT LIMITED
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS
    • YPSOMED AG
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report